Ilika plc (ILIKF) Stock Price & Analysis
ILIKF Stock Chart & Stats
- Day’s Range
- $0.27 - $0.29
- 52-Week Range
- $0.23 - $0.62
- Previous Close
- $0.29
- Volume
- N/A
- Average Volume (3M)
- 51.48K
- Market Cap
- $57.30M
- Enterprise Value
- $55.40M
- Total Cash (Recent Filing)
- $5.35M
- Total Debt (Recent Filing)
- $1.08M
- Price to Earnings (P/E)
- ―
- Beta
- 0.88
- Next Earnings
- Jan 28, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Intellectual Property
An 88-patent portfolio provides defensible technology assets and may support licensing, partnerships and customer adoption. Reported advantages in vehicle weight, charging speed and safety strengthen the potential value proposition as solid-state batteries progress toward commercial use.
Commercialization Partnerships
Cirtec adds wafer scale-up and U.S. manufacturing capability while Ilika retains electrode manufacturing and wafer revenue streams. This partnership creates a credible route from internally developed technology to customer delivery and recurring commercial monetization.
Low Financial Leverage
Very low leverage reduces fixed financial obligations and near-term balance-sheet pressure compared with a highly indebted business. This gives Ilika greater flexibility to direct available funding toward product validation and commercialization while technology revenues develop.
Bears Say
Persistent Unprofitability
Persistent negative margins show that Ilika has not yet demonstrated a scalable, profitable revenue model. Until commercial volumes improve economics, continued operating losses can absorb funding, constrain investment choices and delay the point at which technology growth converts into earnings.
Continued Cash Burn
Ongoing negative operating and free cash flow means the business cannot currently fund operations and development from internally generated cash. Dependence on grants, partnerships and capital raises increases funding risk and may create dilution pressure during scale-up.
Limited Scale And Execution Constraints
Current pilot capacity supports prototypes and some smaller applications but is insufficient for automotive-scale production. Resource trade-offs and lengthy validation timelines could defer larger licensing opportunities, limit product breadth and slow conversion of partnerships into material revenue.
ILIKF FAQ
What was Ilika plc’s price range in the past 12 months?
What is Ilika plc’s market cap?
When is Ilika plc’s upcoming earnings report date?
How were Ilika plc’s earnings last quarter?
Is Ilika plc overvalued?
Does Ilika plc pay dividends?
What is Ilika plc’s EPS estimate?
How many shares outstanding does Ilika plc have?
What happened to Ilika plc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ilika plc?
What is the TipRanks Smart Score and how is it calculated?
Ilika plc Stock Smart Score
Company Description
Ilika plc
Ilika plc, an enterprise established in 2004 with its headquarters in Romsey, United Kingdom, focuses on the conception, refinement, and commercial production of solid-state battery technology. These advanced power cells are distributed globally under their Stereax brand, primarily serving markets in the UK, Asia, mainland Europe, and North America. The company's battery solutions find application across numerous sectors, such as industrial Internet of Things, medical apparatus, various transportation systems including electric vehicles, and portable consumer electronics, as well as supporting smart city initiatives.
- Sector
- Industrials
- Industry
- Electrical Equipment & Parts
- CEO
- Graeme Purdy
- Employees
- 68
- Website
- www.ilika.com
- Address
- The Quadrangle, Romsey, HM, SO51 9DL, GB
Ilika plc (ILIKF) Earnings & Revenues
ILIKF Earnings Call
Earnings Call SentimentNeutral
The call presented meaningful technical and commercial progress: first Stereax revenues, manufacturing partnerships (Cirtec), automated pilot line, positive prototype feedback from OEMs, defense and Brompton collaborations, and continued grant support. However, financials remain an important constraint — revenue is still modest, EBITDA losses widened (~19% year‑on‑year), loss per share increased (~14.9%), and pilot capacity and resource limitations constrain immediate scale‑up. There is clear momentum on the technology and validation front but material execution, funding and timing risks remain.
View all ILIKF earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 5 | 9 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 6 | 0 | 6 |








